These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 13363476)

  • 21. A case of lead poisoning due to snooker chalk.
    Dargan PI; Evans PH; House IM; Jones AL
    Arch Dis Child; 2000 Dec; 83(6):519-20. PubMed ID: 11087293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of acute lead intoxication--choice of chelating agents and supportive therapeutic measures.
    Chisolm JJ
    Clin Toxicol; 1970 Dec; 3(4):527-40. PubMed ID: 4999705
    [No Abstract]   [Full Text] [Related]  

  • 23. [Use of sodium calcium salt of ethylenediaminotetraacetic acid in clinical cases of lead poisoning].
    WEBER M; OPALKO S; ROBAKIEWICZ M
    Pol Arch Med Wewn; 1957; 27(2):215-28. PubMed ID: 13452997
    [No Abstract]   [Full Text] [Related]  

  • 24. [Lead poisoning and detoxication by calcium disodium edathamil; new observations].
    ALBAHARY C; TRUHAUT R; BOUDENE C
    Arch Mal Prof; 1957; 18(1):40-6. PubMed ID: 13412247
    [No Abstract]   [Full Text] [Related]  

  • 25. Two men with lead poisoning.
    St George IM
    N Z Med J; 1970 May; 71(456):294-7. PubMed ID: 4988850
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment guidelines for lead exposure in children. American Academy of Pediatrics Committee on Drugs.
    Pediatrics; 1995 Jul; 96(1 Pt 1):155-60. PubMed ID: 7596706
    [No Abstract]   [Full Text] [Related]  

  • 27. [Problem of the therapy of chronic lead poisoning with ethylenediamine tetraacetic acid calcium disodium].
    SRBOVA J; TEISINGER J
    Arch Gewerbepathol Gewerbehyg; 1956; 14(6):579-93. PubMed ID: 13355405
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical management of lead poisoning.
    Kowalczyk DF
    J Am Vet Med Assoc; 1984 Apr; 184(7):858-60. PubMed ID: 6427161
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of an intravenous chelating agent, edathamil disodium (Na 2-EDTA), in 3 cases of sarcoidosis.
    RUKAVINA JG; ORKIN M; LYNCH FW
    J Invest Dermatol; 1958 Nov; 31(5):259-62. PubMed ID: 13598931
    [No Abstract]   [Full Text] [Related]  

  • 30. The treatment of scleroderma with the new chelating agent, edathamil.
    MULLER SA; BRUNSTING LA; WINKELMANN RK
    AMA Arch Derm; 1959 Aug; 80(2):187-94. PubMed ID: 13669744
    [No Abstract]   [Full Text] [Related]  

  • 31. Chelation therapy in workers exposed to lead. A critical review.
    Lilis R; Fischbein A
    JAMA; 1976 Jun; 235(26):2823-4. PubMed ID: 819666
    [No Abstract]   [Full Text] [Related]  

  • 32. [Recent advance in the therapy of metal poisoning with complexing agents].
    Aaseth J
    Tidsskr Nor Laegeforen; 1972 May; 12(13):918-22. PubMed ID: 4624035
    [No Abstract]   [Full Text] [Related]  

  • 33. [Chelating agents in the treatment of lead poisoning].
    CORBIN JL
    Prog Med (Paris); 1957 Apr 10-24; 85(7-8):159-60; passim. PubMed ID: 13441772
    [No Abstract]   [Full Text] [Related]  

  • 34. [CASE REPORT ON THE TREATMENT OF LEAD POISONING WITH THE CHELATING AGENT NA 2-EDTA IN SMALL DOSES].
    TEICHMANN W
    Z Gesamte Inn Med; 1963 Jul; 18():597-9. PubMed ID: 14047064
    [No Abstract]   [Full Text] [Related]  

  • 35. [On lead poisonings in childhood and their treatment with Ca-EDTA].
    DRUMMEN M; REINL W
    Med Klin; 1962 Apr; 57():604-8. PubMed ID: 13887958
    [No Abstract]   [Full Text] [Related]  

  • 36. Lead poisoning in children and its therapy with EDTA.
    SMITH HD
    Ind Med Surg; 1959 Mar; 28(3):148-51; discussion 151-5. PubMed ID: 13630577
    [No Abstract]   [Full Text] [Related]  

  • 37. Chronic lead poisoning; a case report.
    BURKE LM
    West Indian Med J; 1957 Jun; 6(2):105-7. PubMed ID: 13478020
    [No Abstract]   [Full Text] [Related]  

  • 38. Lead encephalopathy treated by versenate (CA-EDTA).
    Radwan H; Braun H; Bar-Sela S; Kott E
    Eur Neurol; 1982; 21(3):157-60. PubMed ID: 6811276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental lead nephropathy: treatment with calcium disodium ethylenediaminetetraacetate.
    Sánchez-Fructuoso AI; Blanco J; Cano M; Ortega L; Arroyo M; Fernández C; Prats D; Barrientos A
    Am J Kidney Dis; 2002 Jul; 40(1):59-67. PubMed ID: 12087562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of acute hypercalcaemia with a chelating agent.
    BARON DN
    Proc R Soc Med; 1956 Oct; 49(10):728. PubMed ID: 13379383
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.